<p>*For patients taking levodopa drug treatment, scores given in the ‘on’ state.</p>†<p>From Parkinson’s Plus Scale (Cerebellar Score, maximum 24; Occulomotor Score, maximum 21).</p><p>MSA = multiple systems atrophy; PSP = progressive supranuclear palsy; PD = Parkinson’s disease; MSA-P = multiple system atrophy parkinsonian variant; MSA-C = multiple system atrophy cerebellar variant; H&Y = Hoehn and Yahr; ADL = activities of daily living; UPDRS III = Unified Parkinson Disease Rating Scale–part III; MMSE = Mini Mental State Examination; DRS = Mattis Dementia Rating Scale.</p><p>Demographic and clinical data of control subjects and patients with PD, MSA and PSP.</p
none8noThe differential diagnosis between multiple system atrophy with predominant parkinsonism (MSA...
<p>The table shows the clinical characteristics of the Parkinson's disease patients. Duration is yea...
<p>*percentage refers to all persons included in model I (‘possible’ PD).</p>†<p>model II (‘probable...
<p>* For patients taking levodopa drug treatment, scores given in the ‘on’ state.</p>†<p>From Parkin...
<p>Acronyms: M: male; F: female; DD: disease duration; H&Y: Hoehn and Yahr; MMSE: Mini-Mental State ...
<p>DRS-2 = Dementia Rating Scale – 2<sup>nd</sup> Version total raw score (max = 144); WTAR = Wechsl...
<p>Abbreviations: PD, Parkinson's disease; UPDRS, Unified Parkinson's Disease Rating Scale; H&Y, Hoe...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>PD, Parkinson’s disease; MMSE, Mini Mental State Examination; CDR, Clinical Dementia Rating; NPI,...
<p>UPDRS-III, Unified Parkinson’s Disease Rating Scale III; MoCA, Montreal Cognitive Assessment; BDI...
<p>Demographic, clinical and biochemical data of patients with Parkinson’s disease non-demented (PDN...
<p>MADRS = Montgomery-Åsberg Depression Rating Scale; UPDRS = Unified Parkinson's Disease Rating...
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
Parkinson’s disease is a common adult onset neodegenerative disorder , induced mostly by the death o...
a<p>HC vs. PD-NC;</p>b<p>PD-NC vs PD-MCI;</p>c<p>PD-MCI vs. PDD. PD-NC: Parkinson’s disease with nor...
none8noThe differential diagnosis between multiple system atrophy with predominant parkinsonism (MSA...
<p>The table shows the clinical characteristics of the Parkinson's disease patients. Duration is yea...
<p>*percentage refers to all persons included in model I (‘possible’ PD).</p>†<p>model II (‘probable...
<p>* For patients taking levodopa drug treatment, scores given in the ‘on’ state.</p>†<p>From Parkin...
<p>Acronyms: M: male; F: female; DD: disease duration; H&Y: Hoehn and Yahr; MMSE: Mini-Mental State ...
<p>DRS-2 = Dementia Rating Scale – 2<sup>nd</sup> Version total raw score (max = 144); WTAR = Wechsl...
<p>Abbreviations: PD, Parkinson's disease; UPDRS, Unified Parkinson's Disease Rating Scale; H&Y, Hoe...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>PD, Parkinson’s disease; MMSE, Mini Mental State Examination; CDR, Clinical Dementia Rating; NPI,...
<p>UPDRS-III, Unified Parkinson’s Disease Rating Scale III; MoCA, Montreal Cognitive Assessment; BDI...
<p>Demographic, clinical and biochemical data of patients with Parkinson’s disease non-demented (PDN...
<p>MADRS = Montgomery-Åsberg Depression Rating Scale; UPDRS = Unified Parkinson's Disease Rating...
<p>UPDRS-III; Unified Parkinson's Disease Rating Scale part III. LED; levodopa-equivalent dose.</p
Parkinson’s disease is a common adult onset neodegenerative disorder , induced mostly by the death o...
a<p>HC vs. PD-NC;</p>b<p>PD-NC vs PD-MCI;</p>c<p>PD-MCI vs. PDD. PD-NC: Parkinson’s disease with nor...
none8noThe differential diagnosis between multiple system atrophy with predominant parkinsonism (MSA...
<p>The table shows the clinical characteristics of the Parkinson's disease patients. Duration is yea...
<p>*percentage refers to all persons included in model I (‘possible’ PD).</p>†<p>model II (‘probable...